Mayo Clinic Phage Program Biobank
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05314426
- Status
- Enrolling By Invitation
Conditions
- Bacteriophage Therapy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.
Key Dates
- Start date
- Apr 19, 2022
- Status verified
- Jun 2025
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Enrollment of study participants [ Time Frame: 5 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | - |
Find similar trials in Rochester, MN
By research site